Tampere University of Technology

TUTCRIS Research Portal

Differential scanning calorimetry predicts the critical quality attributes of amorphous glibenclamide

Research output: Contribution to journalArticleScientificpeer-review

Details

Original languageEnglish
Pages (from-to)74-81
Number of pages8
JournalEuropean Journal of Pharmaceutical Sciences
Volume80
DOIs
Publication statusPublished - 1 Dec 2015
Publication typeA1 Journal article-refereed

Abstract

Selection of a crystallinity detection tool that is able to predict the critical quality attributes of amorphous formulations is imperative for the development of process control strategies. The main aim of this study was to determine the crystallinity detection tool that best predicts the critical quality attributes (i.e. physical stability and dissolution behaviour) of amorphous material. Glibenclamide (model drug) was milled for various durations using a planetary mill and characterised using Raman spectroscopy and differential scanning calorimetry (DSC). Physical stability studies upon storage at 60 degrees C/0% RH and dissolution studies (non-sink conditions) were performed on the milled glibenclamide samples. Different milling durations were needed to render glibenclamide fully amorphous according to Raman spectroscopy (60 min) and onset of crystallisation using DSC (150 min). This could be due to the superiority of DSC (onset of crystallisation) in detecting residual crystallinity in the samples milled for between 60 and 120 min, which were not detectable with Raman spectroscopy. The physical stability upon storage and dissolution behaviour of the milled samples improved with increased milling duration and plateaus were reached after milling for certain periods of time (physical stability - 150 min; dissolution - 120 min). The residual crystallinity which was detectable with DSC (onset of crystallisation), but not with Raman spectroscopy, adversely affected the critical quality attributes of milled glibenclamide samples. In addition, mathematical simulations were performed on the dissolution data to determine the solubility advantages of the milled glibenclamide samples and to describe the crystallisation process that occurred during dissolution in pH 7.4 phosphate buffer. In conclusion, the onset of crystallisation obtained from DSC measurements best predicts the critical quality attributes of milled glibenclamide samples and mathematical simulations based on the solvent-mediated crystallisation model were successfully performed on the dissolution data. (C) 2015 Elsevier B.V. All rights reserved.

Keywords

  • Amorphous, Critical quality attributes, Crystallinity, Differential scanning calorimetry (DSC), Dissolution, Physical stability, PHARMACEUTICAL SYSTEMS, DISSOLUTION BEHAVIOR, RAMAN-SPECTROSCOPY, DRUGS, INDOMETHACIN, SOLUBILITY, STABILITY, STATE, QUANTIFICATION, COMPRESSION, 317 Pharmacy